The abnormal signaling of the B cell receptor and co-receptors of lupus B cells

Authors: Liossis, Stamatis-Nick C.

Source: In Clinical Immunology June 2024 263

B cell depletion treatment decreases Th17 cells in patients with rheumatoid arthritis

Authors: Bounia, Constantina A., Liossis, Stamatis-Nick C.

Source: In Clinical Immunology December 2021 233

Immune Checkpoint Inhibitor-Associated Scleroderma-Like Syndrome: A Report of a Pembrolizumab-Induced 'Eosinophilic Fasciitis-Like' Case and a Review of the Literature

Authors: Salamaliki, Christina, Solomou, Elena E., Liossis, Stamatis-Nick C.

Source: Rheumatology and therapy. 7(4):1045-1052

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100188981551.0x000001&indx=1&recIds=ETOCvdc_100188981551.0x000001

Th1/17 cells, a subset of Th17 cells, are expanded in patients with active systemic lupus erythematosus

Authors: Tsanaktsi, Anastasia, Solomou, Elena E., Liossis, Stamatis-Nick C.

Source: In Clinical Immunology October 2018 195:101-106

B cell depletion treatment decreases CD4+IL4+ and CD4+CD40L+ T cells in patients with systemic sclerosis

Authors: Antonopoulos, Ioannis, Daoussis, Dimitrios, Lalioti, Maria-Eleni, Markatseli, Theodora E., Drosos, Alexandros A., Taraviras, Stavros, Andonopoulos, Andrew P., Liossis, Stamatis-Nick C.

Source: Rheumatology international. 39(11):1889-1898

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100177613923.0x000001&indx=1&recIds=ETOCvdc_100177613923.0x000001

Roles of the protein tyrosine phosphatase PTPN22 in immunity and autoimmunity

Authors: Fousteri, Georgia, Liossis, Stamatis-Nick C., Battaglia, Manuela

Source: In Clinical Immunology December 2013 149(3) Part B:556-565

Treatment modalities and drug survival in a systemic sclerosis real-life patient cohort

Authors: Panopoulos, S., Chatzidionysiou, Κ., Tektonidou, M. G., Bournia, V. K., Drosos, A. A., Liossis, Stamatis-Nick C., Dimitroulas, T., Sakkas, L., Boumpas, D., Voulgari, P. V., Daoussis, D., Thomas, K., Georgiopoulos, G., Vosvotekas, G., Garyfallos, Α., Sidiropoulos, P., Bertsias, G., Vassilopoulos, D., Sfikakis, P. P.

Source: Arthritis research & therapy. 22(1)

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100171974525.0x000001&indx=1&recIds=ETOCvdc_100171974525.0x000001

Treatment of Systemic Sclerosis-Associated Calcinosis: A Case Report of Rituximab-Induced Regression of CREST-Related Calcinosis and Review of the Literature

Authors: Daoussis, Dimitrios, Antonopoulos, Ioannis, Liossis, Stamatis-Nick C., Yiannopoulos, Georgios, Andonopoulos, Andrew P.

Source: In Seminars in Arthritis and Rheumatism June 2012 41(6):822-829

Treatment with TNFα blockers induces phenotypical and functional aberrations in peripheral B cells

Authors: Karampetsou, Maria P., Andonopoulos, Andrew P., Liossis, Stamatis-Nick C.

Source: In Clinical Immunology 2011 140(1):8-17

Molecular abnormalities of the B cell in systemic lupus erythematosus are candidates for functional inhibition treatments

Authors: Liossis, Stamatis-Nick C, Melissaropoulos, Konstantinos

Source: Expert opinion on pharmacotherapy. 15(6):833-840

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100106505064.0x000001&indx=1&recIds=ETOCvdc_100106505064.0x000001

New onset of lupus nephritis in two patients with SLE shortly after initiation of treatment with belimumab

Authors: Staveri, Chrysanthi, Karokis, Dimitrios, Liossis, Stamatis-Nick C.

Source: Seminars in arthritis and rheumatism. 46(6):788-790

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100044416451.0x000001&indx=1&recIds=ETOCvdc_100044416451.0x000001

Pathogenesis of human systemic lupus erythematosus: recent advances

Authors: Crispín, José C., Liossis, Stamatis-Nick C., Kis-Toth, Katalin, Lieberman, Linda A., Kyttaris, Vasileios C., Juang, Yuang-Taung, Tsokos, George C.

Source: In Trends in Molecular Medicine 2010 16(2):47-57

Is There a Role for B-cell Depletion as Therapy for Scleroderma? A Case Report and Review of the Literature

Authors: Daoussis, Dimitrios, Liossis, Stamatis-Nick C., Tsamandas, Athanassios C., Kalogeropoulou, Christina, Kazantzi, Alexandra, Korfiatis, Panagiotis, Yiannopoulos, Georgios, Andonopoulos, Andrew P.

Source: In Seminars in Arthritis and Rheumatism 2010 40(2):127-136

The Pathophysiologic Role of Monocytes and Macrophages in Systemic Lupus Erythematosus: A Reappraisal

Authors: Katsiari, Christina G., Liossis, Stamatis-Nick C., Sfikakis, Petros P.

Source: In Seminars in Arthritis and Rheumatism 2010 39(6):491-503

Wnt Pathway and IL-17: Novel Regulators of Joint Remodeling in Rheumatic Diseases. Looking Beyond the RANK-RANKL-OPG Axis

Authors: Daoussis, Dimitrios, Andonopoulos, Andrew P., Liossis, Stamatis-Nick C.

Source: In Seminars in Arthritis and Rheumatism 2010 39(5):369-383

Rituximab-induced B cell depletion in autoimmune diseases: Potential effects on T cells

Authors: Liossis, Stamatis-Nick C., Sfikakis, Petros P.

Source: In Clinical Immunology 2008 127(3):280-285

Monoclonal antibodies and fusion proteins in medicine

Authors: Liossis, Stamatis-Nick C., Tsokos, George C.

Source: In The Journal of Allergy and Clinical Immunology 2005 116(4):721-729

Aberrant Expression of the Costimulatory Molecule CD40 Ligand on Monocytes from Patients with Systemic Lupus Erythematosus

Authors: Katsiari, Christina G., Liossis, Stamatis-Nick C., Souliotis, Vassilis L., Dimopoulos, Athanasios M., Manoussakis, Menelaos N., Sfikakis, Petros P.

Source: In Clinical Immunology April 2002 103(1):54-62

B-Cell Depletion Therapy in Systemic Sclerosis: Experimental Rationale and Update on Clinical Evidence.

Authors: Daoussis, Dimitrios¹ jimdaoussis@hotmail.com, Liossis, Stamatis-Nick C.¹, Yiannopoulos, Georgios¹, Andonopoulos, Andrew P.¹

Source: International Journal of Rheumatology. 2011, Vol. 2011, p1-7. 7p. 1 Chart.

Subject Terms: *B cells, *SYSTEMIC scleroderma, *CLINICAL pathology, *LABORATORY mice, *LUNG diseases, *FIBROSIS, *COLLAGEN diseases, *CYTOLOGY

Costimulation Blockade in the Treatment of Rheumatic Diseases.

Authors: Liossis, Stamatis-Nick C.¹, Sfikakis, Petros P.²

Source: BioDrugs. 2004, Vol. 18 Issue 2, p95-102. 8p.

Subject Terms: *ANIMAL models in research, *RHEUMATISM, *ARTHRITIS, *MONOCLONAL antibodies, *LUPUS erythematosus